 |
Discover ~ Translate ~ Cure |
 |
|
Discover ~ Translate ~ Cure |
|
TVG PublicationsBelow is a list of publications by individual investigators at the UW Tumor Vaccine Group over the past two years. For prior years please click on the type of publication in the left menu then the year associated with the publication. To view the article, click on the article title. You must have Adobe Reader to view these articles. If you do not have Adobe Reader, you can download it free from Adobe.com. |
Original Articles |
|
Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer. Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA, Dela Rosa C, Tietje K, Link J, Waisman J, Salazar LG. J Clinical Oncology 27(28):4685-92. (Epub ahead of print 2009) | PubMed# 19720923 |
|
Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen Karyampudi L, Krco CJ, Kalli KR, Erskine CL, Hartmann LC, Goodman K, Ingle JN, Maurer MJ, Nassar A, Yu C, Disis ML, Wettstein PJ, Fikes JD, Beebe M, Ishioka G, and Knutson KL Cancer Immunol Immunother, 2009 (epub ahead of print) |
|
Identification of immunologic biomarkers associated with clinical response after immune-based therapy for cancer Dang Y and Disis ML Annals of the New York Academy of Sciences 1174:81-7. | PubMed #19769740 |
|
Toward a stem cell gene therapy for breast cancer Li Z, Liu Y, Tuve S, Xun Y, Fan X, Min L, Feng Q, Kiviat N, Kiem HP, Disis ML, Lieber A. Blood 113(22): 5423-33, 2009 | PubMed #19329780 |
|
In situ adenovirus vaccination engages T effector cells against cancer. Tuve S, Liu Y, Tragoolpua K, Jacobs JD, Yumul RC, Li ZY, Strauss R, Hellstrom KE, Disis ML, Roffler S, Lieber A. Vaccine 27: 4225-4239, 2009 | PubMed #19481312 |
|
Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced immunity Coveler AL, Goodell V, Webster DJ, Salazar LG, Fintak PA, Childs JS, Higgins DM and Disis ML Breast Cancer Research Treatment 113(1): 95-100, 2009 | PubMed #18236151 |
|
Direct detection of carcinoembryonic antigen autoantibodies in clinical human serum samples using a surface plasmon resonance sensor Ladd J, Lu H, Taylor AD, Goodell V, Disis ML, Jiang S Colloids Surf B Biontefraces 70: 1-6, 2009 | PubMed #19157807 |
|
Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer Park KH, Gad E, Goodell V, Dang Y, Wild T, Higgins D, Fintak P, Childs J, Dela Rosa C, Disis ML Cancer Research 68(20): 8400-9, 2008 | PubMed #18922913 |
|
An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer Kalli KR, Krco CJ, Hartmann LC, Goodman K, Maurer MJ, Yu C, Johnson EM, Erskine CL, Disis ML, Wettstein PJ, Fikes JD, Beebe M, Ishioka G, Knutson KL Cancer Research 68(12): 4893-901, 2008 | PubMed #18559537 |
|
The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity Behrens MD, Wagner WM, Krco CJ, Erskine CL, Kalli KR, Krempski J, Gad EA, Disis ML and Knutson KL Blood 111(3): 1472-9, 2008 | PubMed #18029553 |
|
His-tag ELISA for the detection of humoral tumor-specific immunity Goodell V, McNeel D and Disis ML BMC Immunology 9: 23, 2008 | PubMed #18510754 |
|
Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides Maecker HT, Hassler J, Payne JK, Summers A, Comatas K, Ghanayem M, Morse MA, Clay TM, Lyerly HK, Bhatia S, Ghanekar SA, Maino VC, delaRosa C and Disis ML BMC Immunology 9: 9, 2008 | PubMed #18366814 |
|
An analytical workflow for investigating cytokine profiles Siebert JC, Inokuma M, Waid DM, Pennock ND, Vaitaitis GM, Disis ML, Dunne JF, Wagner DH and Maecker HT Cytometry A 73(4): 289-98, 2008 | PubMed #18163472 |
|
Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunity Goodell V, Waisman J, Salazar LG, dela Rosa C, Link J, Coveler AL, Webster W, Childs JS, Fintak PA, Higgins DM and Disis ML Molecular Cancer Theraputics 7(3): 449-54, 2008 | PubMed #18319334 |
|
Humoral immunity directed against tumor associated antigens as potential biomarkers for the early diagnosis of cancer Lu H, Goodell V, and Disis ML Proteome Res 7: 1388-94, 2008 | PubMed #18311901 |
Review Articles |
|
Use of tumour-responsive T cells as cancer treatment Disis ML, Bernhard H, Jaffee EM. Lancet. 373(9664): 673-83, 2009 | PubMed #19231634 |
|
A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers" Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Thurin M, Trinchieri G, Wang E, Wigginton J, Chaussabel D, Coukos G, Dhodapkar M, Hakansson L, Janetzki S, Kleen TO, Kirkwood JM, Maccalli C, Maecker H, Maio M, Malyguine A, Masucci G, Palucka AK, Potter DM, Ribas A, Rivoltini L, Schendel D, Seliger B, Selvan S, Slingluff CL Jr, Stroncek DF, StreicherH, Wu X, Zeskind B, Zhao Y, Zocca MB, Zwierzina H, Marincola FM. J Translational Medicine. 6: 81, 2008 | PubMed #19105846 |
|
Translational Research Working Group developmental pathway for immune response modifiers. Cheever MA, Schlom J, Weiner LM, Lyerly HK, Disis ML, Greenwood A, Grad O, Nelson WG; Translational Research Working Group. Clinical Cancer Res. 14(18): 5692-9, 2008 | PubMed #18794077 |
|
Tumor stromal barriers to the success of adoptive T cell therapy Phan V and Disis ML Cancer Immunol Immunother 57(2): 281-3, 2008 | PubMed #17646987 |
|
Immune modulation as a therapeutic strategy for non-small-cell lung cancer Holt GE and Disis ML Clin Lung Cancer Suppl 1: S13-9, 2008 | PubMed #18540530 |
|
Cellular immune strategies for cancer therapy Disis ML, Jaffe EM and Bernhard H Lancet (in press), 2008 | Not Published Yet |
Methods from Our Lab |
|
Maximizing the retention of antigen specific lymphocyte function after cryopreservation Disis, M.L., dela rosa, C., Goodell, V., Kuan, L., Chang J. C.C., Kuus-Reichel, K., clay, T.M., Lyerly, K., Bhatia, S., Ghanekar, S.A., Maino, V.C., Maecker, H.T. Journal of Immunological Methods 308 (2006) 13 - 18 |
|
PBMC cryopreservation using human serum albumin The Tumor Vaccine Group *This is the standard operation procedure document used in "Maximizing the retention of antigen specific lymphocyte function after cryopreservation"* referenced in: Journal of Immunological Methods xxx, xxx-xxx, 2005. |
|
Human tumor cell lysates as a protein source for the detection of cancer antigen specific humoral immunity. Goodell V, Disis ML Journal of Immunological Methods 299 (2005) 129– 138 |
|
Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT Maecker HT, Moon J, Bhatia S, Ghanekar SA, Maino VC, Payne JK, Kuus-Reichel K, Chang J, Summers A, Clay TM, Morse MA, Lyerly HK, delaRosa C, Ankerst DP, Disis ML BMC Immunology 2005, 6:17 |
| Please see the Immunologic Monitoring Laboratory for our most up to date methods. |